A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab – a ...

Researchers from Kyushu University have identified a potential therapeutic target for the treatment of advanced multiple sclerosis (MS), a potentially disabling condition associated with the central ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed ...

It has been developed thanks to the collaboration of Sanitas Hospitals, the European University, the Official College of ...

Researchers from Kyushu University have identified a potential therapeutic target for the treatment of advanced multiple sclerosis (MS), a potentially disabling condition associated with the central ...

(Reuters) -Sanofi's most advanced multiple sclerosis drug candidate has missed the main goal of two late-stage trials to treat relapsing forms of the disease, but in a positive surprise succeeded in a ...

Differences in the complexity of the EEG signal (yellow and red colors) in a specific brain area between the group with advanced multiple sclerosis and the control group, and multifractal spectra ...

Explore the unique challenges faced by women with Multiple Sclerosis and the need for holistic care solutions in India.

While recent therapies have the potential to stall or delay the progression of multiple sclerosis, a new study shows that young Black and Hispanic women fare worse than young white women. Minority ...

Multiple sclerosis (MS) is undergoing a meaningful evolution in how it is understood, diagnosed, and managed. Advances in ...

Multiple sclerosis is characterised by central nervous system inflammation and demyelination, which lead to neurodegeneration and impaired neural drive to skeletal muscle. As a result, individuals ...

Researchers say delayed diagnosis, lack of awareness, expensive treatment, and poor access to neurological care continue affecting thousands of patients across the world, including India. Experts say ...